Evogene Ltd (EVGN)

NASDAQ

$0.55

Evogene Ltd., is a computational biology company. The company is headquartered in Rehovot, Israel.

Sector:

Industry:

68 analysts

Buy

Target: $2.15 (+291.34%)

Market Cap

$5.64M

Beta (5Y)

0.76

Adjust inflation

Log

Valuation

Market Cap$5.64M

P/S3.17

P/B6.18

Profitability

Total Revenue (TTM)$1.84M

Gross Profit (TTM)-$863K

EBITDA-$13M

Operating Margin-952%

EPS-$1.38

Financial Health

Debt-to-Equity-79.8%

Growth & Risk

Revenue 5Y CAGR+7.27%

FCF 5Y CAGR-2.54%

Beta (5Y)0.76

Sharpe Ratio-0.97